 Paul MacLean
Concepts (577)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity | 56 | 2025 | 2992 | 5.190 |
Why?
| | Weight Gain | 26 | 2023 | 519 | 4.690 |
Why?
| | Energy Metabolism | 32 | 2024 | 922 | 4.520 |
Why?
| | Weight Loss | 26 | 2025 | 787 | 4.220 |
Why?
| | Physical Conditioning, Animal | 10 | 2025 | 257 | 2.430 |
Why?
| | Rats, Wistar | 19 | 2024 | 455 | 2.280 |
Why?
| | Energy Intake | 18 | 2025 | 485 | 2.200 |
Why?
| | Dietary Fats | 14 | 2019 | 304 | 1.870 |
Why?
| | Caloric Restriction | 9 | 2025 | 124 | 1.800 |
Why?
| | Ovariectomy | 11 | 2025 | 152 | 1.770 |
Why?
| | Body Weight | 16 | 2024 | 985 | 1.530 |
Why?
| | Lactation | 8 | 2020 | 181 | 1.500 |
Why?
| | Adipose Tissue | 15 | 2022 | 635 | 1.450 |
Why?
| | Appetite | 3 | 2025 | 69 | 1.390 |
Why?
| | Diet, High-Fat | 15 | 2023 | 247 | 1.380 |
Why?
| | Milk, Human | 6 | 2022 | 158 | 1.330 |
Why?
| | Body Composition | 12 | 2024 | 684 | 1.240 |
Why?
| | Rats | 34 | 2024 | 5647 | 1.170 |
Why?
| | Adipocytes | 7 | 2025 | 222 | 1.150 |
Why?
| | Muscle, Skeletal | 20 | 2022 | 1724 | 1.130 |
Why?
| | Ovary | 4 | 2024 | 221 | 1.060 |
Why?
| | Fatty Acids, Omega-6 | 2 | 2017 | 48 | 1.060 |
Why?
| | Diet, Fat-Restricted | 6 | 2015 | 79 | 1.060 |
Why?
| | Animals | 77 | 2025 | 36940 | 1.010 |
Why?
| | Fatty Acids, Omega-3 | 2 | 2017 | 140 | 0.980 |
Why?
| | Lipid Metabolism | 9 | 2017 | 518 | 0.970 |
Why?
| | Motor Activity | 3 | 2019 | 718 | 0.960 |
Why?
| | Appetite Regulation | 2 | 2017 | 31 | 0.890 |
Why?
| | Adaptation, Physiological | 7 | 2018 | 553 | 0.850 |
Why?
| | Biomedical Research | 3 | 2023 | 692 | 0.820 |
Why?
| | Liver | 11 | 2024 | 1943 | 0.800 |
Why?
| | Cholesterol | 5 | 2019 | 410 | 0.790 |
Why?
| | Fasting | 7 | 2025 | 281 | 0.780 |
Why?
| | Follicle Stimulating Hormone | 1 | 2024 | 244 | 0.780 |
Why?
| | Leptin | 8 | 2025 | 236 | 0.780 |
Why?
| | Vasopressins | 3 | 2021 | 64 | 0.770 |
Why?
| | Lipoprotein Lipase | 3 | 2021 | 59 | 0.770 |
Why?
| | Overweight | 5 | 2025 | 558 | 0.770 |
Why?
| | Insulin-Like Growth Factor I | 2 | 2023 | 319 | 0.770 |
Why?
| | Body Weight Maintenance | 2 | 2019 | 16 | 0.770 |
Why?
| | Awards and Prizes | 1 | 2023 | 67 | 0.770 |
Why?
| | Eating | 5 | 2022 | 380 | 0.760 |
Why?
| | Estrogens | 3 | 2018 | 367 | 0.760 |
Why?
| | Lipogenesis | 3 | 2019 | 61 | 0.750 |
Why?
| | Breast Feeding | 5 | 2022 | 440 | 0.750 |
Why?
| | Mammary Neoplasms, Experimental | 3 | 2021 | 68 | 0.730 |
Why?
| | Mammary Glands, Animal | 5 | 2019 | 129 | 0.730 |
Why?
| | Glycoproteins | 5 | 2005 | 342 | 0.710 |
Why?
| | Receptor, Insulin | 3 | 2015 | 105 | 0.700 |
Why?
| | Insulin | 19 | 2022 | 2409 | 0.690 |
Why?
| | Exercise | 11 | 2025 | 2057 | 0.670 |
Why?
| | Estradiol | 1 | 2024 | 521 | 0.670 |
Why?
| | Milk | 5 | 2019 | 124 | 0.640 |
Why?
| | Oxygen Consumption | 5 | 2019 | 696 | 0.640 |
Why?
| | Thermogenesis | 2 | 2019 | 44 | 0.640 |
Why?
| | Physical Exertion | 3 | 2011 | 215 | 0.630 |
Why?
| | Female | 64 | 2025 | 73304 | 0.630 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2021 | 218 | 0.630 |
Why?
| | Cold Temperature | 2 | 2019 | 179 | 0.620 |
Why?
| | Carrier Proteins | 6 | 2005 | 771 | 0.610 |
Why?
| | Prenatal Exposure Delayed Effects | 3 | 2018 | 605 | 0.600 |
Why?
| | Sex Characteristics | 3 | 2021 | 762 | 0.590 |
Why?
| | Mitochondria, Muscle | 1 | 2019 | 116 | 0.580 |
Why?
| | Menopause | 2 | 2019 | 320 | 0.580 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 53 | 0.570 |
Why?
| | Breast Neoplasms | 6 | 2022 | 2253 | 0.560 |
Why?
| | Adipogenesis | 1 | 2017 | 55 | 0.550 |
Why?
| | Diet | 10 | 2023 | 1278 | 0.540 |
Why?
| | Cortical Bone | 1 | 2017 | 18 | 0.540 |
Why?
| | Insulin Resistance | 9 | 2025 | 1208 | 0.530 |
Why?
| | Organic Cation Transport Proteins | 1 | 2017 | 26 | 0.530 |
Why?
| | Adiposity | 5 | 2016 | 518 | 0.520 |
Why?
| | Diet, Reducing | 4 | 2021 | 89 | 0.520 |
Why?
| | Mice | 34 | 2025 | 17787 | 0.520 |
Why?
| | Ibuprofen | 1 | 2017 | 84 | 0.520 |
Why?
| | Metformin | 2 | 2018 | 331 | 0.510 |
Why?
| | Placenta | 1 | 2023 | 750 | 0.500 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 99 | 0.500 |
Why?
| | Supraoptic Nucleus | 1 | 2015 | 4 | 0.500 |
Why?
| | Osteogenesis | 2 | 2017 | 188 | 0.500 |
Why?
| | Bone Density | 1 | 2019 | 489 | 0.480 |
Why?
| | Receptors, Estrogen | 1 | 2018 | 436 | 0.480 |
Why?
| | Fructose | 5 | 2021 | 112 | 0.480 |
Why?
| | Oxytocin | 1 | 2015 | 51 | 0.470 |
Why?
| | Gene Expression Regulation | 9 | 2021 | 2607 | 0.470 |
Why?
| | Intra-Abdominal Fat | 2 | 2022 | 91 | 0.460 |
Why?
| | Therapies, Investigational | 1 | 2014 | 17 | 0.450 |
Why?
| | Mothers | 4 | 2018 | 754 | 0.450 |
Why?
| | Male | 58 | 2025 | 67762 | 0.440 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 350 | 0.430 |
Why?
| | Weight Reduction Programs | 3 | 2025 | 117 | 0.430 |
Why?
| | Fatty Acids | 8 | 2022 | 443 | 0.420 |
Why?
| | Fructokinases | 5 | 2021 | 32 | 0.410 |
Why?
| | Transcription Factors | 12 | 2019 | 1719 | 0.410 |
Why?
| | Basal Metabolism | 3 | 2021 | 61 | 0.410 |
Why?
| | Monosaccharide Transport Proteins | 3 | 2002 | 51 | 0.410 |
Why?
| | Disease Models, Animal | 11 | 2021 | 4295 | 0.400 |
Why?
| | Fatty Liver | 5 | 2018 | 243 | 0.390 |
Why?
| | Humans | 68 | 2025 | 137585 | 0.390 |
Why?
| | Overnutrition | 1 | 2012 | 30 | 0.390 |
Why?
| | Blood Glucose | 10 | 2019 | 2186 | 0.380 |
Why?
| | Feeding Behavior | 5 | 2025 | 654 | 0.370 |
Why?
| | Anorexia Nervosa | 1 | 2013 | 89 | 0.370 |
Why?
| | Pregnancy | 9 | 2023 | 6763 | 0.370 |
Why?
| | Recurrence | 4 | 2019 | 1060 | 0.360 |
Why?
| | Diabetes Mellitus | 6 | 2018 | 1040 | 0.360 |
Why?
| | Estrous Cycle | 1 | 2010 | 20 | 0.340 |
Why?
| | Receptors, Progesterone | 1 | 2012 | 350 | 0.340 |
Why?
| | Body Mass Index | 11 | 2025 | 2389 | 0.330 |
Why?
| | Lipoproteins | 3 | 2000 | 168 | 0.330 |
Why?
| | Homeostasis | 7 | 2015 | 621 | 0.330 |
Why?
| | Acetyl-CoA Carboxylase | 4 | 2014 | 33 | 0.330 |
Why?
| | RNA, Messenger | 10 | 2019 | 2833 | 0.330 |
Why?
| | Estrogen Receptor alpha | 2 | 2018 | 145 | 0.320 |
Why?
| | Glucose | 10 | 2023 | 1020 | 0.320 |
Why?
| | Vitamin D | 1 | 2013 | 397 | 0.320 |
Why?
| | Calorimetry, Indirect | 5 | 2021 | 84 | 0.310 |
Why?
| | Insulin-Like Growth Factor II | 2 | 2023 | 22 | 0.310 |
Why?
| | National Institutes of Health (U.S.) | 2 | 2023 | 128 | 0.310 |
Why?
| | Huntington Disease | 2 | 2021 | 57 | 0.300 |
Why?
| | Behavior Therapy | 2 | 2021 | 264 | 0.300 |
Why?
| | Dietary Carbohydrates | 5 | 2019 | 155 | 0.290 |
Why?
| | Gastrointestinal Microbiome | 3 | 2023 | 697 | 0.290 |
Why?
| | Time Factors | 10 | 2019 | 6828 | 0.280 |
Why?
| | Peripheral Blood Stem Cell Transplantation | 1 | 2007 | 24 | 0.270 |
Why?
| | Promoter Regions, Genetic | 5 | 2017 | 1250 | 0.270 |
Why?
| | Mice, Inbred C57BL | 16 | 2025 | 5757 | 0.270 |
Why?
| | Adult | 31 | 2025 | 37929 | 0.270 |
Why?
| | Mammary Glands, Human | 2 | 2020 | 64 | 0.260 |
Why?
| | Triglycerides | 8 | 2019 | 524 | 0.260 |
Why?
| | Neurons | 1 | 2015 | 1590 | 0.260 |
Why?
| | Leukocytes, Mononuclear | 2 | 2021 | 558 | 0.260 |
Why?
| | Adiponectin | 5 | 2025 | 244 | 0.260 |
Why?
| | Transplantation, Autologous | 1 | 2007 | 238 | 0.250 |
Why?
| | Antineoplastic Agents | 2 | 2017 | 2129 | 0.250 |
Why?
| | Mice, Knockout | 12 | 2021 | 3015 | 0.250 |
Why?
| | Dehydration | 2 | 2016 | 51 | 0.250 |
Why?
| | Lymphoma | 1 | 2007 | 208 | 0.250 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2018 | 176 | 0.240 |
Why?
| | Feces | 4 | 2023 | 484 | 0.240 |
Why?
| | Diabetes Mellitus, Type 2 | 5 | 2023 | 2531 | 0.240 |
Why?
| | Adenocarcinoma | 1 | 2012 | 940 | 0.240 |
Why?
| | Epithelium | 2 | 2019 | 313 | 0.240 |
Why?
| | Signal Transduction | 6 | 2022 | 5079 | 0.240 |
Why?
| | Muscle Proteins | 4 | 2012 | 231 | 0.240 |
Why?
| | Metabolic Syndrome | 3 | 2021 | 354 | 0.230 |
Why?
| | Photoperiod | 2 | 2019 | 52 | 0.230 |
Why?
| | Leukemia | 1 | 2007 | 240 | 0.230 |
Why?
| | Sheep | 3 | 2023 | 856 | 0.230 |
Why?
| | Transcriptome | 3 | 2024 | 971 | 0.230 |
Why?
| | Hematopoietic Stem Cells | 2 | 2025 | 406 | 0.220 |
Why?
| | Multiple Myeloma | 1 | 2007 | 252 | 0.220 |
Why?
| | DNA-Binding Proteins | 7 | 2019 | 1502 | 0.220 |
Why?
| | Adipose Tissue, White | 1 | 2024 | 41 | 0.220 |
Why?
| | Physical Fitness | 2 | 2016 | 209 | 0.210 |
Why?
| | Animals, Newborn | 3 | 2017 | 844 | 0.210 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2019 | 283 | 0.210 |
Why?
| | Cholesterol Ester Transfer Proteins | 5 | 2005 | 20 | 0.210 |
Why?
| | Resistance Training | 3 | 2017 | 164 | 0.210 |
Why?
| | Financing, Organized | 1 | 2023 | 35 | 0.200 |
Why?
| | Arteriosclerosis | 1 | 2003 | 88 | 0.200 |
Why?
| | Fetal Development | 2 | 2023 | 296 | 0.200 |
Why?
| | Animal Feed | 3 | 2019 | 53 | 0.200 |
Why?
| | Hospitalization | 1 | 2013 | 2199 | 0.200 |
Why?
| | Transcriptional Activation | 2 | 2002 | 378 | 0.200 |
Why?
| | Sequence Analysis, RNA | 3 | 2021 | 452 | 0.200 |
Why?
| | Ghrelin | 3 | 2025 | 36 | 0.200 |
Why?
| | Cell Proliferation | 3 | 2017 | 2475 | 0.200 |
Why?
| | Parturition | 1 | 2023 | 71 | 0.190 |
Why?
| | Oxidation-Reduction | 6 | 2019 | 1060 | 0.190 |
Why?
| | Tamoxifen | 3 | 2021 | 202 | 0.190 |
Why?
| | Faculty | 1 | 2023 | 147 | 0.190 |
Why?
| | Postmenopause | 4 | 2022 | 366 | 0.190 |
Why?
| | Exercise Tolerance | 3 | 2016 | 279 | 0.190 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2018 | 1396 | 0.180 |
Why?
| | Adipose Tissue, Brown | 2 | 2019 | 53 | 0.180 |
Why?
| | Middle Aged | 22 | 2025 | 33479 | 0.180 |
Why?
| | Malus | 1 | 2021 | 11 | 0.180 |
Why?
| | Polyphenols | 1 | 2021 | 17 | 0.180 |
Why?
| | Mentors | 1 | 2023 | 202 | 0.170 |
Why?
| | Receptors, Vasopressin | 1 | 2021 | 20 | 0.170 |
Why?
| | Thinness | 3 | 2021 | 91 | 0.170 |
Why?
| | Hygromycin B | 1 | 2000 | 3 | 0.170 |
Why?
| | Child Development | 2 | 2018 | 475 | 0.170 |
Why?
| | Liver X Receptors | 2 | 2019 | 31 | 0.170 |
Why?
| | Disease Progression | 4 | 2018 | 2757 | 0.170 |
Why?
| | Cinnamates | 1 | 2000 | 10 | 0.170 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2021 | 161 | 0.170 |
Why?
| | Kynurenine 3-Monooxygenase | 1 | 2020 | 5 | 0.170 |
Why?
| | Hyperinsulinism | 1 | 2001 | 121 | 0.170 |
Why?
| | Fruit | 1 | 2021 | 140 | 0.170 |
Why?
| | Kynurenic Acid | 1 | 2020 | 20 | 0.170 |
Why?
| | Random Allocation | 2 | 2019 | 353 | 0.160 |
Why?
| | Transcription, Genetic | 7 | 2017 | 1457 | 0.160 |
Why?
| | Starch | 1 | 2019 | 22 | 0.160 |
Why?
| | Nutritive Value | 1 | 2019 | 37 | 0.160 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2022 | 412 | 0.160 |
Why?
| | Uncoupling Protein 1 | 1 | 2019 | 16 | 0.160 |
Why?
| | Cattle | 2 | 2019 | 984 | 0.160 |
Why?
| | Iodide Peroxidase | 1 | 2019 | 28 | 0.160 |
Why?
| | Weaning | 1 | 2019 | 47 | 0.160 |
Why?
| | Metabolic Diseases | 2 | 2018 | 108 | 0.150 |
Why?
| | Membrane Proteins | 3 | 2015 | 1164 | 0.150 |
Why?
| | Retinal Ganglion Cells | 1 | 2020 | 110 | 0.150 |
Why?
| | Analysis of Variance | 4 | 2016 | 1316 | 0.150 |
Why?
| | Gene Expression Profiling | 2 | 2018 | 1774 | 0.150 |
Why?
| | Rats, Sprague-Dawley | 8 | 2015 | 2486 | 0.150 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2020 | 195 | 0.150 |
Why?
| | Hyperuricemia | 1 | 2018 | 44 | 0.150 |
Why?
| | Loss of Function Mutation | 1 | 2018 | 46 | 0.150 |
Why?
| | Mice, Transgenic | 7 | 2017 | 2167 | 0.150 |
Why?
| | Aromatase | 1 | 2018 | 32 | 0.140 |
Why?
| | Mammary Neoplasms, Animal | 1 | 2018 | 33 | 0.140 |
Why?
| | Rest | 1 | 2018 | 121 | 0.140 |
Why?
| | Perilipin-1 | 1 | 2017 | 17 | 0.140 |
Why?
| | Bile Acids and Salts | 1 | 2019 | 200 | 0.140 |
Why?
| | Glycogen | 6 | 2010 | 55 | 0.140 |
Why?
| | Models, Animal | 1 | 2019 | 384 | 0.140 |
Why?
| | Sodium Chloride, Dietary | 1 | 2018 | 36 | 0.140 |
Why?
| | Fetal Growth Retardation | 1 | 2023 | 565 | 0.140 |
Why?
| | Postpartum Period | 2 | 2020 | 340 | 0.140 |
Why?
| | Diglycerides | 1 | 2018 | 61 | 0.140 |
Why?
| | Cell Size | 1 | 2017 | 91 | 0.140 |
Why?
| | Germ Layers | 1 | 2017 | 6 | 0.140 |
Why?
| | Urea | 1 | 2017 | 81 | 0.140 |
Why?
| | Gastrulation | 1 | 2017 | 9 | 0.140 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2017 | 70 | 0.140 |
Why?
| | Sphingolipids | 1 | 2018 | 77 | 0.140 |
Why?
| | Sucrose | 2 | 2018 | 110 | 0.140 |
Why?
| | Reperfusion Injury | 1 | 2020 | 279 | 0.140 |
Why?
| | Tumor Microenvironment | 2 | 2018 | 674 | 0.140 |
Why?
| | Organic Cation Transporter 2 | 1 | 2017 | 8 | 0.130 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2017 | 62 | 0.130 |
Why?
| | Running | 1 | 2019 | 230 | 0.130 |
Why?
| | Liquid-Liquid Extraction | 1 | 2016 | 14 | 0.130 |
Why?
| | Interdisciplinary Communication | 1 | 2018 | 191 | 0.130 |
Why?
| | Chromatography, Gas | 1 | 2016 | 33 | 0.130 |
Why?
| | Neural Pathways | 2 | 2011 | 295 | 0.130 |
Why?
| | Dogs | 1 | 2018 | 413 | 0.130 |
Why?
| | Cellular Reprogramming | 1 | 2017 | 99 | 0.130 |
Why?
| | Glaucoma | 1 | 2020 | 237 | 0.130 |
Why?
| | Dyslipidemias | 1 | 2018 | 176 | 0.130 |
Why?
| | PPAR gamma | 1 | 2017 | 182 | 0.130 |
Why?
| | Diabetes, Gestational | 1 | 2020 | 318 | 0.130 |
Why?
| | Receptors, Androgen | 1 | 2017 | 150 | 0.120 |
Why?
| | Alloxan | 1 | 2015 | 4 | 0.120 |
Why?
| | Corpus Striatum | 1 | 2017 | 167 | 0.120 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 4 | 2019 | 57 | 0.120 |
Why?
| | Fibroblasts | 2 | 2017 | 996 | 0.120 |
Why?
| | Obesity, Morbid | 1 | 2000 | 264 | 0.120 |
Why?
| | Computational Biology | 1 | 2020 | 644 | 0.120 |
Why?
| | Hypothalamus | 1 | 2016 | 153 | 0.120 |
Why?
| | Glucokinase | 1 | 2015 | 15 | 0.120 |
Why?
| | CCAAT-Enhancer-Binding Protein-alpha | 2 | 2006 | 15 | 0.120 |
Why?
| | Down-Regulation | 3 | 2008 | 657 | 0.120 |
Why?
| | Malonyl Coenzyme A | 1 | 1995 | 5 | 0.120 |
Why?
| | Methylnitrosourea | 2 | 2018 | 7 | 0.120 |
Why?
| | Microbiota | 1 | 2023 | 762 | 0.120 |
Why?
| | Colorectal Neoplasms | 1 | 2023 | 806 | 0.120 |
Why?
| | Pediatric Obesity | 1 | 2022 | 601 | 0.120 |
Why?
| | Trophoblasts | 1 | 2017 | 199 | 0.120 |
Why?
| | Cholesterol, LDL | 3 | 2003 | 365 | 0.110 |
Why?
| | Caffeine | 1 | 1995 | 68 | 0.110 |
Why?
| | Protein Processing, Post-Translational | 1 | 2017 | 465 | 0.110 |
Why?
| | In Vitro Techniques | 2 | 2015 | 1092 | 0.110 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 279 | 0.110 |
Why?
| | Homeodomain Proteins | 1 | 2018 | 506 | 0.110 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2017 | 248 | 0.110 |
Why?
| | Infant | 5 | 2023 | 9465 | 0.110 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 2 | 2005 | 37 | 0.110 |
Why?
| | Research Report | 1 | 2014 | 83 | 0.110 |
Why?
| | Acinar Cells | 1 | 2013 | 13 | 0.110 |
Why?
| | United States | 3 | 2023 | 14841 | 0.110 |
Why?
| | Circadian Rhythm | 2 | 2009 | 468 | 0.100 |
Why?
| | Pantothenic Acid | 1 | 2013 | 6 | 0.100 |
Why?
| | Mitochondria | 3 | 2022 | 948 | 0.100 |
Why?
| | Bariatric Surgery | 1 | 2017 | 217 | 0.100 |
Why?
| | Mitochondria, Liver | 1 | 2013 | 73 | 0.100 |
Why?
| | Birth Weight | 1 | 2016 | 516 | 0.100 |
Why?
| | Vitamin A Deficiency | 1 | 2013 | 26 | 0.100 |
Why?
| | Vitamin A | 1 | 2013 | 58 | 0.100 |
Why?
| | Immunohistochemistry | 2 | 2017 | 1738 | 0.100 |
Why?
| | Extracellular Space | 1 | 2013 | 119 | 0.100 |
Why?
| | Intestinal Mucosa | 2 | 2015 | 623 | 0.100 |
Why?
| | Integrases | 1 | 2013 | 120 | 0.100 |
Why?
| | Class Ia Phosphatidylinositol 3-Kinase | 1 | 2012 | 7 | 0.100 |
Why?
| | Oxidative Phosphorylation | 1 | 2013 | 193 | 0.100 |
Why?
| | DNA Methylation | 1 | 2017 | 643 | 0.100 |
Why?
| | Cell Separation | 1 | 2013 | 318 | 0.100 |
Why?
| | Up-Regulation | 2 | 2013 | 843 | 0.100 |
Why?
| | Cytoskeleton | 1 | 2013 | 191 | 0.090 |
Why?
| | Enzyme Inhibitors | 1 | 2015 | 840 | 0.090 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2017 | 860 | 0.090 |
Why?
| | Hormones | 2 | 2010 | 143 | 0.090 |
Why?
| | Histones | 1 | 2017 | 636 | 0.090 |
Why?
| | Epithelial Cells | 2 | 2020 | 1096 | 0.090 |
Why?
| | Chloramphenicol O-Acetyltransferase | 2 | 2002 | 38 | 0.090 |
Why?
| | Research Design | 1 | 2018 | 1139 | 0.090 |
Why?
| | Morphogenesis | 1 | 2012 | 166 | 0.090 |
Why?
| | Interleukin-10 | 1 | 2013 | 302 | 0.090 |
Why?
| | Biomarkers | 6 | 2019 | 4149 | 0.090 |
Why?
| | Multienzyme Complexes | 2 | 2001 | 68 | 0.090 |
Why?
| | Vitamin D Deficiency | 1 | 2013 | 186 | 0.090 |
Why?
| | Glycolysis | 1 | 2012 | 321 | 0.090 |
Why?
| | Cardiovascular Diseases | 2 | 2022 | 2111 | 0.090 |
Why?
| | Colon | 1 | 2013 | 282 | 0.090 |
Why?
| | Pulmonary Alveoli | 1 | 2013 | 405 | 0.090 |
Why?
| | Infant, Newborn | 3 | 2018 | 6079 | 0.080 |
Why?
| | Patient Compliance | 1 | 2014 | 581 | 0.080 |
Why?
| | Colorado | 2 | 2019 | 4565 | 0.080 |
Why?
| | Lipoproteins, VLDL | 2 | 2000 | 18 | 0.080 |
Why?
| | Metalloproteases | 1 | 2010 | 43 | 0.080 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2012 | 366 | 0.080 |
Why?
| | Perilipin-2 | 3 | 2015 | 41 | 0.080 |
Why?
| | Alkylating Agents | 1 | 2009 | 24 | 0.080 |
Why?
| | Acetaminophen | 1 | 2012 | 268 | 0.080 |
Why?
| | Bone and Bones | 1 | 2012 | 317 | 0.080 |
Why?
| | Mitochondrial Proteins | 2 | 2010 | 257 | 0.080 |
Why?
| | Species Specificity | 1 | 2011 | 585 | 0.080 |
Why?
| | Fats | 1 | 2009 | 17 | 0.080 |
Why?
| | Adolescent | 6 | 2025 | 21513 | 0.080 |
Why?
| | Cholesterol, HDL | 2 | 2000 | 203 | 0.080 |
Why?
| | Glucose Clamp Technique | 2 | 2018 | 195 | 0.080 |
Why?
| | Hypertension | 1 | 2018 | 1295 | 0.080 |
Why?
| | Young Adult | 6 | 2025 | 13209 | 0.080 |
Why?
| | Health Behavior | 1 | 2014 | 762 | 0.080 |
Why?
| | Hypoglycemic Agents | 2 | 2017 | 1291 | 0.080 |
Why?
| | Lipid Peroxidation | 1 | 2009 | 153 | 0.070 |
Why?
| | Interleukin-4 | 1 | 2009 | 216 | 0.070 |
Why?
| | Self Report | 1 | 2013 | 827 | 0.070 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2013 | 351 | 0.070 |
Why?
| | AMP-Activated Protein Kinases | 3 | 2014 | 197 | 0.070 |
Why?
| | Disease Susceptibility | 3 | 2016 | 347 | 0.070 |
Why?
| | Genetic Predisposition to Disease | 1 | 2017 | 2426 | 0.070 |
Why?
| | Interleukin-2 | 1 | 2009 | 455 | 0.070 |
Why?
| | Cross-Over Studies | 2 | 2021 | 564 | 0.070 |
Why?
| | Hematopoietic Stem Cell Mobilization | 1 | 2007 | 22 | 0.070 |
Why?
| | Hyperplasia | 1 | 2008 | 175 | 0.070 |
Why?
| | Phosphorylation | 2 | 2012 | 1759 | 0.070 |
Why?
| | Risk Factors | 3 | 2018 | 10388 | 0.070 |
Why?
| | Antigens, CD34 | 1 | 2007 | 88 | 0.070 |
Why?
| | Treatment Outcome | 3 | 2016 | 10811 | 0.070 |
Why?
| | Metabolic Networks and Pathways | 2 | 2022 | 180 | 0.070 |
Why?
| | Patient Selection | 2 | 2009 | 696 | 0.070 |
Why?
| | Body Temperature Regulation | 1 | 2008 | 97 | 0.070 |
Why?
| | Leukocyte Count | 1 | 2007 | 329 | 0.060 |
Why?
| | Cell Line | 3 | 2019 | 2847 | 0.060 |
Why?
| | Lactates | 3 | 1995 | 85 | 0.060 |
Why?
| | Exercise Test | 1 | 2009 | 625 | 0.060 |
Why?
| | Transplantation Conditioning | 1 | 2007 | 170 | 0.060 |
Why?
| | Calorimetry | 3 | 2012 | 70 | 0.060 |
Why?
| | Carbohydrate Metabolism | 1 | 2006 | 59 | 0.060 |
Why?
| | Interleukin-6 | 2 | 2022 | 778 | 0.060 |
Why?
| | Gluconeogenesis | 1 | 2006 | 79 | 0.060 |
Why?
| | Peptide YY | 1 | 2025 | 17 | 0.060 |
Why?
| | Reference Values | 1 | 2007 | 816 | 0.060 |
Why?
| | Cell Differentiation | 1 | 2013 | 1991 | 0.060 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2022 | 1477 | 0.060 |
Why?
| | Retrospective Studies | 3 | 2018 | 15657 | 0.060 |
Why?
| | Glucose Transporter Type 4 | 2 | 2002 | 40 | 0.060 |
Why?
| | Sterol Regulatory Element Binding Protein 2 | 1 | 2005 | 7 | 0.060 |
Why?
| | Models, Biological | 2 | 2018 | 1783 | 0.060 |
Why?
| | Lipolysis | 1 | 2005 | 46 | 0.060 |
Why?
| | Case-Control Studies | 3 | 2019 | 3556 | 0.060 |
Why?
| | Proteomics | 2 | 2022 | 1111 | 0.060 |
Why?
| | Proteins | 2 | 2013 | 1009 | 0.060 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2025 | 131 | 0.060 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2006 | 220 | 0.060 |
Why?
| | Pilot Projects | 2 | 2022 | 1710 | 0.060 |
Why?
| | Antigens, CD | 1 | 2007 | 521 | 0.060 |
Why?
| | Macrophages | 1 | 2012 | 1547 | 0.050 |
Why?
| | Kinetics | 2 | 2012 | 1670 | 0.050 |
Why?
| | Organ Specificity | 1 | 2005 | 305 | 0.050 |
Why?
| | Myogenic Regulatory Factors | 2 | 2001 | 57 | 0.050 |
Why?
| | MEF2 Transcription Factors | 2 | 2001 | 61 | 0.050 |
Why?
| | Cholesterol, VLDL | 1 | 2003 | 5 | 0.050 |
Why?
| | RNA, Small Interfering | 1 | 2006 | 622 | 0.050 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2005 | 382 | 0.050 |
Why?
| | Endoplasmic Reticulum | 2 | 2018 | 265 | 0.050 |
Why?
| | Food Deprivation | 1 | 2003 | 25 | 0.050 |
Why?
| | Occult Blood | 1 | 2023 | 34 | 0.050 |
Why?
| | Protein Kinases | 2 | 2002 | 319 | 0.050 |
Why?
| | Hexokinase | 1 | 2022 | 19 | 0.050 |
Why?
| | Absorptiometry, Photon | 1 | 2004 | 259 | 0.050 |
Why?
| | Isophane Insulin, Human | 1 | 2022 | 5 | 0.050 |
Why?
| | Aged | 5 | 2018 | 23961 | 0.050 |
Why?
| | Matrix Metalloproteinase 1 | 1 | 2022 | 22 | 0.050 |
Why?
| | Ethers | 1 | 2022 | 19 | 0.050 |
Why?
| | Lactic Acid | 4 | 2002 | 305 | 0.050 |
Why?
| | Culture Media, Conditioned | 1 | 2022 | 110 | 0.050 |
Why?
| | Predictive Value of Tests | 2 | 2021 | 2031 | 0.050 |
Why?
| | Adipokines | 1 | 2022 | 49 | 0.050 |
Why?
| | Phosphatidylethanolamines | 1 | 2022 | 77 | 0.050 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2022 | 86 | 0.050 |
Why?
| | Leucine | 1 | 2022 | 111 | 0.050 |
Why?
| | Rodentia | 1 | 2022 | 57 | 0.050 |
Why?
| | Subcutaneous Fat | 1 | 2022 | 81 | 0.050 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 2 | 2013 | 42 | 0.050 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2022 | 125 | 0.050 |
Why?
| | Diphtheria Toxin | 1 | 2022 | 66 | 0.050 |
Why?
| | Docosahexaenoic Acids | 1 | 2022 | 84 | 0.050 |
Why?
| | Dinoprostone | 1 | 2022 | 191 | 0.050 |
Why?
| | Mice, Obese | 1 | 2021 | 66 | 0.050 |
Why?
| | Aminoimidazole Carboxamide | 1 | 2001 | 12 | 0.050 |
Why?
| | Interleukin-13 | 1 | 2022 | 149 | 0.050 |
Why?
| | Aromatase Inhibitors | 1 | 2021 | 54 | 0.050 |
Why?
| | Neutrophils | 1 | 2007 | 1238 | 0.050 |
Why?
| | Interleukin-8 | 1 | 2022 | 268 | 0.050 |
Why?
| | Diabetes Complications | 1 | 2003 | 227 | 0.050 |
Why?
| | Waist Circumference | 1 | 2021 | 143 | 0.040 |
Why?
| | Tumor Burden | 1 | 2022 | 309 | 0.040 |
Why?
| | Phospholipids | 1 | 2022 | 223 | 0.040 |
Why?
| | Hep G2 Cells | 1 | 2021 | 67 | 0.040 |
Why?
| | Drinking | 1 | 2021 | 42 | 0.040 |
Why?
| | Hemoglobins | 1 | 2023 | 353 | 0.040 |
Why?
| | Blotting, Southern | 1 | 2000 | 73 | 0.040 |
Why?
| | Intestines | 2 | 2015 | 357 | 0.040 |
Why?
| | Colonoscopy | 1 | 2023 | 245 | 0.040 |
Why?
| | Calmodulin | 1 | 2000 | 76 | 0.040 |
Why?
| | Hindlimb | 3 | 1995 | 128 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2022 | 730 | 0.040 |
Why?
| | Calcineurin | 1 | 2000 | 108 | 0.040 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2020 | 100 | 0.040 |
Why?
| | Lipoproteins, HDL | 1 | 2000 | 77 | 0.040 |
Why?
| | Genes, Reporter | 1 | 2000 | 269 | 0.040 |
Why?
| | Aged, 80 and over | 3 | 2018 | 7635 | 0.040 |
Why?
| | Lipoproteins, LDL | 1 | 2000 | 116 | 0.040 |
Why?
| | Medicago sativa | 1 | 2019 | 3 | 0.040 |
Why?
| | Dairying | 1 | 2019 | 7 | 0.040 |
Why?
| | Rumen | 1 | 2019 | 7 | 0.040 |
Why?
| | 3-Hydroxybutyric Acid | 1 | 2019 | 17 | 0.040 |
Why?
| | Benzylamines | 1 | 2019 | 41 | 0.040 |
Why?
| | New Zealand | 1 | 2019 | 56 | 0.040 |
Why?
| | Benzoates | 1 | 2019 | 43 | 0.040 |
Why?
| | Protein Kinase C | 1 | 2000 | 261 | 0.040 |
Why?
| | Postprandial Period | 1 | 2019 | 107 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2019 | 199 | 0.040 |
Why?
| | Child | 2 | 2022 | 21935 | 0.040 |
Why?
| | Prospective Studies | 2 | 2023 | 7604 | 0.040 |
Why?
| | Mathematical Concepts | 1 | 2018 | 31 | 0.040 |
Why?
| | Cross-Sectional Studies | 3 | 2018 | 5472 | 0.040 |
Why?
| | Japan | 1 | 2018 | 115 | 0.040 |
Why?
| | Dietary Proteins | 1 | 2019 | 135 | 0.040 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2019 | 137 | 0.040 |
Why?
| | Huntingtin Protein | 1 | 2017 | 13 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2023 | 1946 | 0.040 |
Why?
| | Early Detection of Cancer | 1 | 2023 | 447 | 0.040 |
Why?
| | Transfection | 1 | 2000 | 945 | 0.040 |
Why?
| | Sarcolemma | 1 | 2018 | 43 | 0.040 |
Why?
| | Stromal Cells | 1 | 2018 | 112 | 0.040 |
Why?
| | Trinucleotide Repeat Expansion | 1 | 2017 | 29 | 0.040 |
Why?
| | Nuclear Transfer Techniques | 1 | 2017 | 3 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 313 | 0.030 |
Why?
| | Comparative Genomic Hybridization | 1 | 2017 | 30 | 0.030 |
Why?
| | Neoplasms | 1 | 2012 | 2671 | 0.030 |
Why?
| | Recombinant Fusion Proteins | 1 | 2000 | 665 | 0.030 |
Why?
| | Blastocyst | 1 | 2017 | 48 | 0.030 |
Why?
| | Cytokines | 2 | 2018 | 2085 | 0.030 |
Why?
| | Muscle Contraction | 1 | 2000 | 424 | 0.030 |
Why?
| | Estrogen Replacement Therapy | 1 | 1998 | 146 | 0.030 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2017 | 27 | 0.030 |
Why?
| | Brain | 2 | 2021 | 2668 | 0.030 |
Why?
| | Breast | 1 | 2018 | 151 | 0.030 |
Why?
| | Phenylthiohydantoin | 1 | 2017 | 42 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1242 | 0.030 |
Why?
| | Cyclic AMP | 2 | 1995 | 234 | 0.030 |
Why?
| | Cytosol | 1 | 2018 | 226 | 0.030 |
Why?
| | Biological Specimen Banks | 1 | 2018 | 102 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2000 | 611 | 0.030 |
Why?
| | Uric Acid | 1 | 2018 | 163 | 0.030 |
Why?
| | Meat | 1 | 2018 | 94 | 0.030 |
Why?
| | Isoenzymes | 2 | 2012 | 304 | 0.030 |
Why?
| | Water Deprivation | 1 | 2016 | 5 | 0.030 |
Why?
| | Erythrocytes | 1 | 2022 | 700 | 0.030 |
Why?
| | Ectoderm | 1 | 2017 | 53 | 0.030 |
Why?
| | Epinephrine | 2 | 1994 | 139 | 0.030 |
Why?
| | Animals, Genetically Modified | 1 | 2017 | 240 | 0.030 |
Why?
| | Methylation | 1 | 2017 | 230 | 0.030 |
Why?
| | Progesterone | 1 | 1998 | 254 | 0.030 |
Why?
| | Fertilization in Vitro | 1 | 2017 | 83 | 0.030 |
Why?
| | Nutrition Surveys | 1 | 2018 | 266 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2020 | 1178 | 0.030 |
Why?
| | Principal Component Analysis | 1 | 2017 | 195 | 0.030 |
Why?
| | Glucose Tolerance Test | 1 | 2018 | 366 | 0.030 |
Why?
| | Nitriles | 1 | 2017 | 172 | 0.030 |
Why?
| | Organ Culture Techniques | 1 | 2016 | 156 | 0.030 |
Why?
| | Steroids | 1 | 2017 | 167 | 0.030 |
Why?
| | Benzamides | 1 | 2017 | 216 | 0.030 |
Why?
| | Teratoma | 1 | 2017 | 114 | 0.030 |
Why?
| | Stem Cells | 1 | 2020 | 594 | 0.030 |
Why?
| | Linear Models | 1 | 2018 | 849 | 0.030 |
Why?
| | Fibroblast Growth Factors | 1 | 2017 | 172 | 0.030 |
Why?
| | Chromatography, Liquid | 1 | 2017 | 433 | 0.030 |
Why?
| | Phosphocreatine | 1 | 1995 | 46 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2022 | 1317 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2019 | 1993 | 0.030 |
Why?
| | Adenosine Monophosphate | 1 | 1995 | 66 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2014 | 4193 | 0.030 |
Why?
| | Fructosediphosphates | 1 | 1994 | 1 | 0.030 |
Why?
| | Fatty Acid Synthases | 1 | 2014 | 24 | 0.030 |
Why?
| | Calcium | 1 | 2000 | 1199 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 852 | 0.030 |
Why?
| | Rats, Inbred Strains | 1 | 2014 | 362 | 0.030 |
Why?
| | Biopsy | 1 | 2018 | 1129 | 0.030 |
Why?
| | Perfusion | 1 | 1995 | 213 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2017 | 739 | 0.030 |
Why?
| | Lipids | 1 | 1998 | 672 | 0.030 |
Why?
| | Hot Temperature | 1 | 2016 | 391 | 0.030 |
Why?
| | Homocysteine S-Methyltransferase | 1 | 2013 | 5 | 0.030 |
Why?
| | Cell Respiration | 1 | 2013 | 103 | 0.030 |
Why?
| | Testosterone | 1 | 2017 | 409 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3284 | 0.030 |
Why?
| | Laser Capture Microdissection | 1 | 2013 | 33 | 0.030 |
Why?
| | Betaine | 1 | 2013 | 73 | 0.030 |
Why?
| | Mice, 129 Strain | 1 | 2013 | 88 | 0.030 |
Why?
| | Muscles | 1 | 1994 | 326 | 0.030 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2015 | 549 | 0.020 |
Why?
| | Fatty Acids, Nonesterified | 3 | 2002 | 159 | 0.020 |
Why?
| | Epigenesis, Genetic | 1 | 2017 | 660 | 0.020 |
Why?
| | Alkaline Phosphatase | 1 | 2012 | 148 | 0.020 |
Why?
| | Sex Factors | 1 | 2018 | 2071 | 0.020 |
Why?
| | Intestine, Small | 1 | 2013 | 156 | 0.020 |
Why?
| | Collagen Type I | 1 | 2012 | 136 | 0.020 |
Why?
| | Prevalence | 1 | 2018 | 2734 | 0.020 |
Why?
| | Blood Pressure | 1 | 2018 | 1786 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2013 | 767 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2018 | 2844 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2013 | 305 | 0.020 |
Why?
| | Metabolism | 1 | 2010 | 42 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2013 | 513 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2000 | 1809 | 0.020 |
Why?
| | Hypoglycemia | 1 | 1994 | 445 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2017 | 3412 | 0.020 |
Why?
| | Glycerol | 1 | 2009 | 94 | 0.020 |
Why?
| | Liver Glycogen | 2 | 2002 | 17 | 0.020 |
Why?
| | Risk Assessment | 1 | 2018 | 3457 | 0.020 |
Why?
| | Proteome | 1 | 2013 | 472 | 0.020 |
Why?
| | Phenotype | 2 | 2008 | 3196 | 0.020 |
Why?
| | Trans-Activators | 1 | 2010 | 398 | 0.020 |
Why?
| | Birds | 1 | 2008 | 93 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2010 | 622 | 0.020 |
Why?
| | Body Temperature | 1 | 2008 | 222 | 0.020 |
Why?
| | Peptides | 1 | 2012 | 985 | 0.020 |
Why?
| | Carbon Radioisotopes | 1 | 2006 | 34 | 0.020 |
Why?
| | Palmitates | 1 | 2006 | 18 | 0.020 |
Why?
| | Orphan Nuclear Receptors | 1 | 2006 | 15 | 0.020 |
Why?
| | Breeding | 1 | 2006 | 64 | 0.020 |
Why?
| | Glucose-6-Phosphatase | 1 | 2006 | 33 | 0.020 |
Why?
| | Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2006 | 32 | 0.020 |
Why?
| | PPAR alpha | 1 | 2006 | 58 | 0.020 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2006 | 32 | 0.020 |
Why?
| | Intestinal Absorption | 1 | 2006 | 102 | 0.020 |
Why?
| | Adenoviridae | 1 | 2006 | 193 | 0.010 |
Why?
| | Introns | 1 | 2005 | 258 | 0.010 |
Why?
| | Enteral Nutrition | 1 | 2006 | 202 | 0.010 |
Why?
| | Carbon Dioxide | 1 | 2006 | 267 | 0.010 |
Why?
| | Enzymes | 1 | 2003 | 67 | 0.010 |
Why?
| | Uncoupling Protein 3 | 1 | 2002 | 8 | 0.010 |
Why?
| | Oxazoles | 1 | 2002 | 37 | 0.010 |
Why?
| | Ketones | 1 | 2002 | 49 | 0.010 |
Why?
| | Thiazoles | 1 | 2002 | 123 | 0.010 |
Why?
| | Inflammation | 1 | 2013 | 2837 | 0.010 |
Why?
| | Ion Channels | 1 | 2002 | 133 | 0.010 |
Why?
| | Ribonucleotides | 1 | 2001 | 26 | 0.010 |
Why?
| | Tyrosine | 1 | 2002 | 222 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2001 | 810 | 0.010 |
Why?
| | Aging | 1 | 2010 | 1864 | 0.010 |
Why?
| | RNA | 1 | 2003 | 921 | 0.010 |
Why?
| | Administration, Oral | 1 | 1998 | 816 | 0.010 |
Why?
| | Adrenal Medulla | 1 | 1994 | 9 | 0.010 |
Why?
| | Molecular Weight | 1 | 1995 | 335 | 0.010 |
Why?
| | Phosphofructokinase-1 | 1 | 1994 | 7 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1995 | 345 | 0.010 |
Why?
| | Cyclic GMP | 1 | 1994 | 93 | 0.010 |
Why?
| | Age Factors | 1 | 2000 | 3295 | 0.010 |
Why?
| | Blotting, Western | 1 | 1995 | 1226 | 0.010 |
Why?
| | Regional Blood Flow | 1 | 1994 | 474 | 0.010 |
Why?
|
|
MacLean's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|